Exchange Agreements in the Health Care Equipment & Supplies Industry
283 Contracts & Agreements
- Accelerate Diagnostics, Inc (4 contracts)
- ACCURAY INC (5)
- Acutus Medical, Inc. (3)
- AETHLON MEDICAL INC (1)
- AIT Therapeutics, Inc. (3)
- Alphatec Holdings, Inc. (2)
- AMERICAN BIO MEDICA CORP (1)
- ANTARES PHARMA, INC. (1)
- Apogee Therapeutics, Inc. (2)
- Apyx Medical Corp (1)
- Arch Therapeutics, Inc. (2)
- Arcturus Therapeutics Ltd. (1)
- ARGOS THERAPEUTICS INC (3)
- Arno Therapeutics, Inc (3)
- Axonics Modulation Technologies, Inc. (1)
- BIOLIFE SOLUTIONS INC (1)
- BIOMIMETIC THERAPEUTICS, INC. (3)
- Bionik Laboratories Corp. (3)
- Bionovate Technologies Corp. (3)
- Cascadian Therapeutics, Inc. (2)
- CHF Solutions, Inc. (1)
- Civitas Therapeutics, Inc. (1)
- CORNERSTONE THERAPEUTICS INC (1)
- CryoLife, Inc. (12)
- Cryoport, Inc. (1)
- CV THERAPEUTICS INC (2)
- Dare Bioscience, Inc. (1)
- DarioHealth Corp. (3)
- DELCATH SYSTEMS, INC. (4)
- Durata Therapeutics, Inc. (4)
- Echo Therapeutics, Inc. (2)
- EKSO BIONICS HOLDINGS, INC. (3)
- ENDOLOGIX INC (2)
- ENDRA Life Sciences Inc. (1)
- ESCALON MEDICAL CORP (1)
- FIGS, Inc. (2)
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (2)
- GUIDED THERAPEUTICS INC (38)
- Haemonetics (1)
- HealthCor Catalio Acquisition Corp. (4)
- Heska Corporation (1)
- Holly Brothers Pictures, Inc. (1)
- Hologic (3)
- InspireMD, Inc. (6)
- Insys Therapeutics, Inc. (1)
- Integrity Applications, Inc. (2)
- INTERACTIVE THERAPEUTICS, INC. (1)
- Invacare Corporation (4)
- INVIVO THERAPEUTICS HOLDINGS CORP. (1)
- INVO Bioscience, Inc. (1)
- Lantheus Holdings, Inc. (4)
- Lucid Diagnostics Inc. (1)
- MABVAX THERAPEUTICS HOLDINGS, INC. (5)
- MAGNA LAB INC (2)
- MICRO THERAPEUTICS INC (1)
- Microbot Medical Inc. (3)
- Modular Medical, Inc. (1)
- Motus GI Holdings, Inc. (1)
- Nemaura Medical Inc. (1)
- NeuroMetrix, Inc. (1)
- NEXEON MEDSYSTEMS INC (1)
- NON INVASIVE MONITORING SYSTEMS INC (2)
- NOVELION THERAPEUTICS INC. (2)
- OBALON THERAPEUTICS INC (1)
- Ocata Therapeutics, Inc. (1)
- OraSure Technologies, Inc. (1)
- ORCHESTRA THERAPEUTICS, INC. (3)
- Orexigen Therapeutics, Inc. (3)
- Oxford Immunotec Global PLC (20)
- PAVmed Inc. (0)
- PERNIX THERAPEUTICS HOLDINGS, INC. (4)
- PetVivo Holdings, Inc. (2)
- Precision Therapeutics Inc. (5)
- Presbia PLC (1)
- Q Therapeutics, Inc. (2)
- QUIDEL CORP (3)
- RemSleep Holdings Inc. (2)
- Restoration Robotics, Inc. (3)
- RetinalGenix Technologies Inc. (5)
- Salona Global Medical Device Corp (1)
- SANUWAVE Health, Inc. (1)
- SeaSpine Holdings Corp (1)
- Senseonics Holdings, Inc. (2)
- Sientra, Inc. (1)
- Sintx Technologies, Inc. (3)
- Spark Therapeutics, Inc. (8)
- Stereotaxis, Inc. (3)
- STRATA Skin Sciences, Inc. (1)
- Structure Therapeutics Inc. (1)
- Surmodics, Inc. (2)
- Talon Therapeutics, Inc. (2)
- Targanta Therapeutics Corp. (1)
- TearLab Corp (2)
- TechCare Corp. (1)
- Tenon Medical, Inc. (3)
- TRANSENTERIX INC. (1)
- VERMILLION, INC. (2)
- VIVEVE MEDICAL, INC. (3)
- VOLITIONRX LTD (1)
- VYCOR MEDICAL INC (1)
- West Pharmaceutical Services (2)
- WOUND MANAGEMENT TECHNOLOGIES, INC. (2)
- Xtant Medical Holdings, Inc. (2)
- YBCC, Inc. (1)
- Zosano Pharma Corp (2)
- Exchange Agreement dated April 15, 2024 (GUIDED THERAPEUTICS INC, Filed With SEC on August 14, 2024)
- Exchange Agreement, dated May 24, 2024, by and among Venus Concept Inc., Venus Concept USA Inc., Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP (Restoration Robotics, Inc., Filed With SEC on May 28, 2024)
- Exchange Agreement, dated as of April 8, 2024 (Invacare Corporation, Filed With SEC on April 10, 2024)
- Exchange Agreement, dated as of April 3, 2024, by and among the registrant, Dermal Diagnostics Limited, Trial Clinic Limited, and Uptown Capital, LLC (Nemaura Medical Inc., Filed With SEC on April 10, 2024)
- Form of Preferred Exchange Agreement by and between DarioHealth Corp. and certain holders of Series A-1 Preferred Stock, dated September 20, 2022 (DarioHealth Corp., Filed With SEC on March 28, 2024)
- Form of Exchange Agreement (Lucid Diagnostics Inc., Filed With SEC on March 14, 2024)
- Form of Exchange Agreement (Integrity Applications, Inc., Filed With SEC on February 16, 2024)
- First Amendment to Note Exchange Agreement, dated December 11, 2023, between the Company and certain investors named therein (Accelerate Diagnostics, Inc, Filed With SEC on December 13, 2023)
- Share Exchange Agreement by and between INVO Bioscience, Inc. and Cytovia Therapeutics Holdings, Inc. dated as of November 19, 2023 (INVO Bioscience, Inc., Filed With SEC on November 20, 2023)
- Exchange Agreement, dated October 4, 2023, by and among Venus Concept Inc., Madryn Health Partners, LP and Madryn Health Partners (Cayman Master), LP (Restoration Robotics, Inc., Filed With SEC on October 5, 2023)
- Contribution and Exchange Agreement, effective July 13, 2023, by and among the Company and the Unit Holders named therein (Apogee Therapeutics, Inc., Filed With SEC on August 28, 2023)
- Form of Exchange Agreement, dated August 10, 2023 (Senseonics Holdings, Inc., Filed With SEC on August 10, 2023)
- Form of Contribution and Exchange Agreement (Apogee Therapeutics, Inc., Filed With SEC on July 3, 2023)
- Note Exchange Agreement, date June 9, 2023, between the Company and certain investors named therein (Accelerate Diagnostics, Inc, Filed With SEC on June 13, 2023)
- Exchange Agreement dated May 10, 2023 between the registrant and the investors named therein (Structure Therapeutics Inc., Filed With SEC on May 11, 2023)
- Form of Exchange Agreement, dated March 10, 2023 (Arch Therapeutics, Inc., Filed With SEC on March 17, 2023)
- Exchange Agreement, dated March 13, 2023, by and between Senseonics Holdings, Inc. and PHC Holdings Corporation (Senseonics Holdings, Inc., Filed With SEC on March 15, 2023)
- Form of Preferred Exchange Agreement by and between DarioHealth Corp. and certain holders of Series A-1 Preferred Stock, dated September 20, 2022 (DarioHealth Corp., Filed With SEC on March 9, 2023)
- Amendment #1 to Exchange Agreement between the Company and Auctus Fund, LLC (GUIDED THERAPEUTICS INC, Filed With SEC on November 14, 2022)
- Exchange Agreement, dated October 12, 2022, by and between Sientra, Inc. and Deerfield Partners, L.P (Sientra, Inc., Filed With SEC on October 12, 2022)
- Share Exchange Agreement, dated as of October 4, 2022, by and among (Glucose Biosensor Systems (Greater China) Holdings, Inc., Filed With SEC on October 11, 2022)
- Exchange Agreement between the Company and Auctus Fund, LLC (GUIDED THERAPEUTICS INC, Filed With SEC on September 15, 2022)
- Exchange Agreement, dated as of August 15, 2022, by and between the Company and the Jack W. Schuler Living Trust (Accelerate Diagnostics, Inc, Filed With SEC on August 15, 2022)
- Exchange Agreement, dated as of July 5, 2022, by and among RetinalGenix Technologies, Inc. DNA/GPS Inc. and Lawrence Perich (RetinalGenix Technologies Inc., Filed With SEC on July 7, 2022)
- EXCHANGE AGREEMENT (GUIDED THERAPEUTICS INC, Filed With SEC on June 30, 2022)
- Exchange Agreement, dated May 9, 2022, with Sanovas Opthalmology, LLC (RetinalGenix Technologies Inc., Filed With SEC on May 13, 2022)
- Exchange Agreement dated October 28, 2021 between the Registrant, Zuhlke Ventures AG and Tenon Technology AG (Tenon Medical, Inc., Filed With SEC on April 7, 2022)
- Exchange Agreement dated February 1, 2022, by and between Guided Therapeutics, Inc. and Auctus Fund LLC (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- EXCHANGE AGREEMENT (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 30, 2021, by and between Guided Therapeutics, Inc. and Dolores Maloof (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 30, 2021, by and between Guided Therapeutics, Inc. and Bryan Mamula (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and Michael C. James (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and GPB Debt Holdings II LLC (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 21, 2021, by and between Guided Therapeutics, Inc. and Flynn D. Case Living Trust (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and Mark L. Faupel (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and Gene S. Cartwright (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 16, 2021, by and between Guided Therapeutics, Inc. and K2 Medical, LLC (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 16, 2021, by and between Guided Therapeutics, Inc. and Richard P. Blumberg, Esq (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 13, 2021, by and between Guided Therapeutics, Inc. and Frederick Grimm (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
- Exchange Agreement, dated as of December 20, 2021, by and between Guided Therapeutics, Inc. and John Gould (GUIDED THERAPEUTICS INC, Filed With SEC on March 30, 2022)
